Chesapeake Partners Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Chesapeake Partners Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$2.02M	Hold	8,399,624	–	–	0.3%	31
2016 Q1	$958K	Hold	8,399,624	–	–	0.07%	55
2015 Q4	$945K	Hold	8,399,624	–	–	0.05%	94
2015 Q3	$1.6M	Buy	8,399,624 +50,000	+0.6%	+$17K	0.08%	96
2015 Q2	$5.84M	Hold	8,349,624	–	–	0.22%	98
2015 Q1	$5.66M	Hold	8,349,624	–	–	0.26%	81
2014 Q4	$6.6M	Buy	8,349,624 +485,660	+6%	+$332K	0.25%	84
2014 Q3	$3.66M	Buy	7,863,964 +5,988	+0.1%	+$2.9K	0.13%	97
2014 Q2	$3.93M	Buy	7,857,976 +2,096,022	+36%	+$1.01M	0.12%	95
2014 Q1	$1.84M	Buy	5,761,954 +715,000	+14%	+$266K	0.07%	94
2013 Q4	$1.72M	Buy	5,046,954 +4,502,954	+828%	+$5.44M	0.08%	87
2013 Q3	$1.1M	Hold	544,000	–	–	0.05%	87
2013 Q2	$1.03M	Buy	+544,000	New	+$956K	0.07%	88

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chesapeake Partners Management's GCVRZ Position: Q2 2016 in Review

Chesapeake Partners Management held its Sanofi Contingent Value Rights (GCVRZ) position steady in Q2 2016 at 8,399,624 shares worth $2.02M. The position accounts for 0.3% of the portfolio, ranked #31.

Chesapeake Partners Management first reported a position in GCVRZ in Q2 2013 and has held it in 13 quarters since. The position peaked at $6.6M in Q4 2014. 109 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2016.

Chesapeake Partners Management held 8,399,624 shares of Sanofi Contingent Value Rights worth $2.02M as of Q2 2016.
Chesapeake Partners Management left its Sanofi Contingent Value Rights share count unchanged in Q2 2016.
Sanofi Contingent Value Rights made up 0.3% of Chesapeake Partners Management's portfolio in Q2 2016, its #31 holding.
Chesapeake Partners Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 13 quarters since.
Chesapeake Partners Management's Sanofi Contingent Value Rights position peaked at $6.6M in Q4 2014.
109 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2016.

Based on Chesapeake Partners Management's 13F filing for Q2 2016, filed 15 Aug 2016.